COMPANY PROFILE · UPDATED 01 AUG 2026

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health…

gilgameshpharmaceutical.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2019
Headcount: 24
Open roles: 0
Last raised: Grant · Sign in to view

LEADERSHIP

Founders & key people

Dalibor Sames

Founder at Gilgamesh Pharmaceuticals

Gilgamesh PharmaceuticalsColumbia University

Andrew Kruegel

President at Kures

KuresColumbia UniversityRocheGilgamesh PharmaceuticalsColumbia UniversityStevens Institute of Technology

Jonathan Sporn

CEO at Gilgamesh Pharmaceuticals

Gilgamesh PharmaceuticalsPerception NeurosciencePfizer Inc.Johnson & JohnsonJohnson & Johnson Pharmaceutical Research & DevelopmentJohnson & Johnson Pharamceutical Research and Development (JJPRD)University of Miami, Miller School of MedicineDuke University

Jeff Witkin

CEO at Witkin Consulting Group

Witkin Consulting GroupLaboratory of Antiepileptic Drug Discovery, Peyton Manning Hospital for ChildrenRespireRx Pharmaceuticals InDepartment of Chemistry & Biochemistry, University Wisconsin-MilwaukeeEli Lilly and CompanyNIDA Intramural Research ProgramUniversity of North Carolina at Chapel Hill - UNCUniversity of Maryland

Mike Cunningham

Founder at Gilgamesh Pharmaceuticals

Gilgamesh PharmaceuticalsColumbia UniversityUniversity of MississippiUniversity of Mississippi, Office of Research and Sponsored ProgramsUniversity of Mississippi, Graduate Student CouncilESL Conversation Partners Program, Texas State UniversityMississippi State UniversityUniversity of Mississippi

OPEN ROLES

Hiring at Gilgamesh Pharmaceuticals

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$82,559,845

Investors

Y Combinator Offline VenturesAlumni Ventures GroupBossa InvestGaingelsGron VenturesIncisive VenturesJLS FundNational Institute on Drug Abuse (NIDA)Negev CapitalNoetic FundNoveus CapitalPalo SantoPrime Movers LabRand HindiRoute 66 VenturesSatori CapitalWPSS.bioWhat If Ventures

Funding rounds

Grant
National Institute on Drug Abuse (NIDA)
$14MMar 13, 2024
Series B
Prime Movers Lab, Gron Ventures, Negev Capital, Alumni Ventures Group, Palo Santo, Satori Capital, Route 66 Ventures, JLS Fund, WPSS.bio
$39MDec 14, 2022
Series A
Prime Movers Lab, Noetic Fund, Route 66 Ventures, Gron Ventures, JLS Fund, Palo Santo, Gaingels, Alumni Ventures Group
$27MMay 5, 2021
Seed
Y Combinator, What If Ventures, Offline Ventures, Bossa Invest, Incisive Ventures
$125KAug 23, 2020
Seed
Rand Hindi, Noveus Capital
$2.4MJul 26, 2020

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Y Combinator Offline Ventures

Industries

Medical Organizations Health Care Companies Biotechnology Companies

LOCATIONS

Where they work

Gilgamesh Pharmaceuticals Headquarters Location

113 University Pl, New York, NY, 10003

Loading map…